EBAC

European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC

Delisted

EBAC was delisted on the 2nd of March, 2023.

Back to rankings

31 hedge funds and large institutions have $40.2M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.04M
2
+$4.81M
3
+$3.15M
4
SCM
Suvretta Capital Management
New York
+$2.92M
5
WP
Woodline Partners
California
+$2.65M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.04M
2
$4.81M
3
$3.15M
4
$2.92M
5
$2.65M
6
$1.95M
7
$1.94M
8
$1.46M
9
$1.45M
10
$1.45M
11
$1.43M
12
$1.21M
13
$1.21M
14
$1.21M
15
$974K
16
$966K
17
$966K
18
$731K
19
$531K
20
$487K
21
$441K
22
$425K
23
$409K
24
$386K
25
$338K
1
2